Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Affymetrix, Inc. (NasdaqNM:AFFX)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Options | Financials | Reports
Recent Events
July 24Price hit new 52-week low ($17.37)
Location
3380 Central Expressway
Santa Clara, CA 95051
Phone: (408) 731-5000
Fax: (408) 481-0422
Email: investor@affymetrix.com
Employees (last reported count): 744
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Websites
 ·Home Page
 ·Employment
 ·Products & Services
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 30%
·Over the last 6 months:
 · 3 insider sells; 1.08M shares
  (5.9% of insider shares)
·Institutional: 53% (76% of float)
(400 institutions)
·Net Inst. Selling: 2.85M shares (+10.24%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Affymetrix, Inc. is engaged in the field of DNA chip technology. Affymetrix has developed and intends to establish its GeneChip system and related microarray technologies as platforms for acquiring, analyzing and managing genetic information. The GeneChip system consists of disposable DNA probe arrays containing gene sequences on a chip, certain reagents for use with the probe arrays, a scanner and other instruments to process the probe arrays and software to analyze and manage genetic information from the probe arrays. Related microarray technology offered includes instrumentation, software and licenses for fabricating, scanning, collecting and analyzing results from low-density microarrays. The Company sells its products directly to pharmaceutical and biotechnology companies, academic research centers, private foundations and clinical reference laboratories in the United States and Europe. The Company also sells its products through certain distributors, principally in Japan.
More from Market Guide: Expanded Business Description

Financial Summary
AFFX develops GeneChip based products and related technology for the acquisition, analysis and management of complex genetic data. The Company sells its products to pharmaceutical and biotechnology companies. For the six months ended 6/30/01, revenues rose 22% to $104.4 million. Net loss rose 61% to $19.9 million. Revenues reflect increased sales of GeneChip(R) probe arrays. Higher loss suffered from $9.4 million in amortization expenses.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Compensation
PayExer

Stephen Fodor, Ph.D., 47
CEO and Chairman
$620K$6.7M
Susan Siegel, 40
Pres
--  5.4M
John Diekman, Ph.D., 58
Vice Chairman
--  --  
Gregory Schiffman
CFO, VP
--  --  
Barbara Caulfield
Exec. VP, Gen. Counsel
--  --  
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:AFFXAs of 31-Aug-2001
Price and Volume
52-Week Low
on 24-July-2001
$17.37 
Recent Price$21.70 
52-Week High
on 8-Nov-2000
$92.00 
Beta1.73 
Daily Volume (3-month avg)1.71M
Daily Volume (10-day avg)894.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change-72.5%
52-Week Change
relative to S&P500
-63.1%
Share-Related Items
Market Capitalization$1.26B
Shares Outstanding57.8M
Float40.5M
Dividends & Splits
Annual Dividendnone 
Last Split: 2 for 1 on 22-Aug-2000
Per-Share Data
Book Value (mrq)$2.32 
Earnings (ttm)-$1.09 
Earnings (mrq)-$0.16 
Sales (ttm)$3.79 
Cash (mrq)$6.43 
Valuation Ratios
Price/Book (mrq)9.35 
Price/EarningsN/A 
Price/Sales (ttm)5.72 
Income Statements
Sales (ttm)$219.6M
EBITDA (ttm)-$58.5M
Income available to common (ttm)-$61.5M
Profitability
Profit Margin (ttm)-28.0%
Operating Margin (ttm)-32.4%
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-10.21%
Return on Equity (ttm)-41.34%
Financial Strength
Current Ratio (mrq)7.51 
Debt/Equity (mrq)2.79 
Total Cash (mrq)$372.0M
Short Interest
As of 8-Aug-2001
Shares Short3.54M
Percent of Float8.7%
Shares Short
(Prior Month)
3.83M
Short Ratio3.26 
Daily Volume1.09M
See Profile Help for a description of each item above;   K = thousands;   M = millions;   B = billions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.